Pupillary cholinergic hypersensitivity predicts cognitive decline in community dwelling elders

Neurobiology of Aging

Volumn 29, Issue 2, 2008, Pages 222-230

  Scinto, Leonard F M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Alzheimer's disease; ApoE; Diagnosis; Risks

Indexed keywords

APOLIPOPROTEIN E; TROPICAMIDE;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC ACTIVITY; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; LANGUAGE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MYDRIASIS; NEUROPSYCHOLOGICAL TEST; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUPIL; PUPIL REFLEX; RISK ASSESSMENT; RISK FACTOR; SURVIVAL;

ACETYLCHOLINE; AGED; AGED, 80 AND OVER; AGING; COGNITION DISORDERS; FEMALE; HUMANS; HYPERSENSITIVITY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; REFLEX, PUPILLARY; RESIDENCE CHARACTERISTICS;

EID: 37549029160     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.10.002     Document Type: Article

References (65)

1. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders. fourth ed. (1994), American Psychiatric Association, Washington, DC
2. Arai H., Terajima M., Nakagawa T., Higuchi S., Mochizuki H., and Sasaki H. Pupil dilation assay by tropicamide is modulated by apolipoprotein Eε4 allele dosage in Alzheimer's disease. NeuroReport 7 (1996) 918-920
3. Benton A.L., DeS Hamsher K., Varney N.R., and Spreen O. Contributions to Neuropsychological Assessment (1983), Oxford University Press, Oxford
4. Blessed G., Tomlinson B.E., and Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 114 (1968) 797-811
5. Byrne C., Brinton L.A., Haile R.W., and Schairer C. Heterogeneity of the effect of family history on breast cancer risk. Epidemiology 2 4 (1991) 276-284
6. Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., Masdeu J., Kawas C., Aronson M., and Wolfson L. Clinical-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38 (1991) 1682-1687
7. Ferrario E., Molaschi M., Villa L., Varetto O., Bogetto C., and Nuzzi R. Is videopupillography useful in the diagnosis of Alzheimer's disease?. Neurology 50 (1998) 642-644
8. Filskov S.B., and Leli D.A. Assessment of the individual in neuropsychological practice. In: Filskov S.b., and Boll T.J. (Eds). Handbook of Clinical Neuropsychology (1981), John Wiley & Sons, New York 545-576
9. FitzSimon J.S., Waring S.C., Kokmen E., McLaren J.W., and Brubaker R.F. Response of the pupil to tropicamide is not a reliable test for Alzheimer's disease. Arch. Neurol. 54 (1997) 155-159
10. Flicker C., Ferris S.H., and Reisberg B. A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 34 (1993) 294-295
11. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., and Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungholmen Project, Stockholm. Neurology 48 1 (1997) 132-138
12. Fridh M., Havelius U., Elofsson G., and Hindfelt B. The pupillary response to tropicamide in Alzheimer's disease. Acta Ophthalmol. Scand. 74 (1996) 276-279
13. Gomez-Isla T., Price J.L., McKeel Jr. D.W., Morris J.C., Growdon J.H., and Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16 14 (1996) 4491-4500
14. Growdon J.H., Graefe K., Tennis M., Hayden D., Schoenfeld D., and Wray S.H. Pupil dilation to tropicamide is not specific for Alzheimer's disease. Neurology 48 (1997) A378
15. Hart S., Smith C.M., and Swash M. Word fluency in patients with early dementia of the Alzheimer's type. Br. J. Clin. Psychol. 27 (1988) 115-124
16. Hasegawa N.A., Collin C., Hosein C.A., Chertow H., and Overbury O. Evaluation of tropicamide in the diagnosis of early Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 38 (1997) S392
17. Haxby J.V., Grady C.L., Duara R., Schlageter N., Berg G., and Rapoport S.I. Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Arch. Neurol. 43 (1986) 882-885
18. Higuchi S., Matsushita S., Hasegawa Y., Muramatsu T., Arai H., and Hayashida M. Apolipoprotein Eε4 allele and pupillary response to tropicamide. Am. J. Psychiatry 154 (1997) 694-696
19. Higuchi S., Matsushita S., Hasegawa Y., Muramatsu T., and Arai H. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia. Exp. Neurol. 144 (1997) 199-201
20. Hubbard B.M., Fenton G.W., and Anderson J.M. A quantitative histological study of early clinical and preclinical Alzheimer's disease. Neuropath. Appl. Neurobiol. 16 (1990) 111-121
21. Idiaquez J., Alvarez G., Villagra R., and San Martin R.A. Cholinergic supersensitivity of the iris in Alzheimer's disease (letter). J. Neurol. Neurosurg. Psychiatry 57 (1994) 1544-1545
22. Jacobs D.M., Sano M., Dooneief G., Marder K., Bell K.L., and Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 45 (1995) 957-962
23. Johansson K., Bogdanovic N., Kalimo H., Winblad B., and Viitanen M. Alzheimer's disease and apolipoprotein Eε4 allele in older drivers who died in automobile accidents. Lancet 349 (1997) 1143-1144
24. Kalman J., Kanka A., Magloczky E., Szoke A., Jardanhazy T., and Janka Z. Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's disease. Biol. Psychiatry 41 (1997) 909-911
25. Kaneyuki H., Mitsuno S., Nishida T., and Yamada M. Enhanced miotic response to topical dilute pilocarpine in patients with Alzheimer's disease. Neurology 50 (1998) 802-804
26. Kaplan E., Goodglass H., and Weintraub S. The Boston Naming Test: Assessment of Aphasia and Related Disorders (1983), Lea & Febiger, Philadelphia
27. Kardon R.H. Drop the Alzheimer's drop test. Neurology 50 (1998) 588-591
28. Katz B. Detecting Alzheimer's disease (letter). Science 67 (1995) 1577-1581
29. Katzman R., Terry R., DeTeresa R., Brown T., Davies P., Fuld P., Renbing X., and Peck H. Clinical, pathological, and neurobiological changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23 (1988) 138-144
30. Kono K., Miyao M., Ishihara S., Takagi A., Ikari K., Suzuki Y., and Iguchi A. Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome. Nippon Ronen Igakkai Zasshi 33 (1996) 829-834
31. Leszek J., Gasiorowski K., and Wojtowicz B. Pupil dilation by tropicamide in Alzheimer's disease patients and probands. Neurobiol. Aging 17 (1996) S164
32. Lezak M.D. Neuropsychological Assessment (1995), Oxford University Press, New York
33. Linn R.T., Wolf P.A., Bachman D.L., Knoefel J.E., Cobb J.L., Belanger A.J., Kaplan E.F., and D'Agostino R.B. The "preclinical phase" of probable Alzheimer's disease. Arch Neurol. 52 (1995) 485-490
34. Litvan I., and FitzGibbon E. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?. Neurology 47 (1996) 1324-1326
35. Martin A., and Fedio P. Word production and comprehension in Alzheimer's disease: the breakdown of semantic knowledge. Brain Lang. 19 1 (1983) 124-141
36. Marx J.L., Kumar S.R., Thach A.B., Kiat-Winarko T., and Frambach D.A. Detecting Alzheimer's disease (letter). Science 267 (1995) 1577-1581
37. Masur D.M., Fuld P.A., Blau A.D., Thal L.J., Levin H.S., and Aronson M.K. Distinguishing normal and demented elderly with the Selective Reminding Test. J. Clin. Exp. Neuropsychol. 11 (1989) 615-630
38. Masur D.M., Sliwinski M., Lipton R.B., Blau A.D., and Crystal H.A. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 44 (1994) 1427-1432
39. Matsushita S., Arai H., Hasegawa Y., Terajima M., Muramatsu T., Sasaki H., and Higuchi S. Apolipoprotein Eε4 allele and pupillary response to tropicamide in Alzheimer's disease and cognitively normal subjects. Neurobiol. Aging 17 (1996) S164
40. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1994) 939-944
41. Miller T.Q. Statistical methods for describing temporal order in longitudinal research. J. Clin. Epidemiol. 50 10 (1997) 1155-1168
42. Monsch A.U., Bondi M.W., Butters N., Salmon D., Katzman R., and Thal L.J. Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer's type. Arch. Neurol. 49 (1992) 1253-1258
43. Morris J.C., Mohs R.C., Rogers H., Fillenbaum G., and Neyman A. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol. Bull. 24 4 (1988) 641-652
44. Morris J.C., McKeel D.W., Storandt M., Rubin E.H., Price J.L., Grant E.A., Ball M.J., and Berg L. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 41 (1991) 469-478
45. Morris J.C., Storandt M., McKeel D.W., Rubin E.H., Price J.L., Grant E.A., and Berg L. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46 (1996) 707-719
46. Nelson H.E., and McKenna P. The use of current reading ability in the assessment of dementia. Br. J. Soc. Clin. Psychol. 14 (1975) 259-267
47. Nuzzi R., Bogetto C., Ferrario E., Molaschi L., Villa L., Varetto O., and Grignolo F.M. Alzheimer's disease and computerized pupillography. Neurobiol. Aging 17 (1996) S165
48. Pajak A. Myocardial infarction-threats and medical care. Longitudinal observations in a population of 280,000 women and men, Project POL-MONICA Krakow. II. Risk factors and mortality due to ischemic heart disease in men ages 35-64. Przegl. Lek. 53 (1996) 707-712
49. Petersen R.C., Smith G.E., Ivnik R.J., Kokmen E., and Tangalos E.G. Memory function in very early Alzheimer's disease. Neurology 44 (1994) 867-872
50. Rentz D.M., Huh T., Faust R., Budson A., Scinto L., Sperling R., and Daffner K. Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology 18 1 (2004) 38-49
51. Schweitzer I., Chang V., Kabov J., Ames D., Vingrys A., and Tuckwell V. Anticholinergic eye drops in differentiating Alzheimer's disease and depression. Biol. Psychiatry 39 (1996) 662 (Abstract)
52. Scinto L.F., Daffner K.R., Dressler D., Ransil B.J., Rentz D., Weintraub S., Mesulam M., and Potter H. A potential noninvasive neurobiological test for Alzheimer's disease. Science 226 (1994) 1051-1054
53. Scinto L.F.M., Wu C.K., Firla K.M., Daffner K.R., Saroff D., and Geula C. Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivity in Alzheimer's disease. Acta Neuropathol. 97 6 (1999) 557-564
54. Scinto L., Frosch M.P., Wu C.K., Daffner K., Gedi N., and Geula C. Selective cell loss in Edinger-Westphal in asymptomatic elders and Alzheimer's patients. Neurobiol. Aging 22 (2001) 729-736
55. Scinto, L. ApoE allelic variability influences pupil response to cholinergic challenge & cognitive impairment. Genes Brain Behav., in press, available online 8 June 2006.
56. Sliwinski M., Lipton R.B., Bushke H., and Stewart W. The effects of preclinical dementia on estimates of normal cognitive functioning in aging. J. Gerontol. 51B (1996) 217-225
57. Sitaram N., and Pomara P. Increased pupillary miotic response to pilocarpine in cognitively impaired elderly subjects. IRCS Medical Science: Clinical and Therapeutics; Clinical Medicine; The Eye; Nervous System. Pathology 9 (1981) 409-410
58. Tang M.X., Maestre G., Tsi W.Y., Liu X.H., Feng L., Chung W.Y., Chun M., Schofield P., Stern Y., Tycko B., and Mayeux R. Relative risk of Alzheimer's disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am. J. Hum. Genet. 58 3 (1996) 574-584
59. Tierney M.C., Szalai J.P., Snow W.G., and Fisher R.M. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 46 (1996) 661-665
60. Tourino R., Robles A., Santos L., Capeans C., and Sanchez-Salorio M. Diagnosis of Alzheimer's disease by using the tropicamide test. Invest. Ophthalmol. Vis. Sci. 38 (1997) S391
61. Ulrich J. Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer's type. Ann. Neurol. 17 (1985) 273-277
62. Wechsler D. Wechsler Adult Intelligence Scale: Revised Manual (1981), The Psychological Corporation, New York
63. Willett J.B., and Singer J.D. Investigating onset, cessation, relapse, and recovery: why you should, and how you can, use discrete-time survival analysis to examine event occurrence. J. Consult. Clin. Psychol. 61 6 (1993) 952-965
64. Woodruf-Pak D.S., Romano S.J., and Hinchliffe M. Detection of Alzheimer's disease with eyeblink classical conditioning and the pupil dilation response. Alzheimer's Res. 2 (1996) 173-180
65. Yesavage J.A., Brink T.L., Rose T.L., et al. Development and validation of a geriatric depression screening scale. J. Psychiatr. Res. 17 (1983) 37-49